In the spotlight

News

Call to Action of Concerned Stakeholders on the implementation of the EU HTA and JCA for ATMPs

Call to Action of Concerned Stakeholders on the implementation of the EU HTA and Joint Clinical Assessment for ATMPs

Request for Proposals (RFP) to Host Annual EAHAD Congress 2027

Request for Proposals (RFP) to Host Annual EAHAD Congress 2027 Are you a clinician actively involved in the haemophilia

EU Elections 2024: Call to Action

EU Elections 2024: Call to Action With the EU Elections 2024 less than a week away, the European Association

EAHAD-EHA-EHC Joint Support Statement on the EMA draft Guideline

EAHAD-EHA-EHC Joint Support Statement on the EMA draft Guideline for the clinical requirements for non-replacement therapy in haemophilia A

EAHAD Statement on Upcoming ISTH Guidelines on Haemophilia Treatment

EAHAD Statement on upcoming ISTH Guidelines on Haemophilia Treatment Brussels, 28 May 2024 The European Association for Haemophilia and

Cell and Gene Therapy Summit 2024

Cell and Gene Therapy Summit 2024

Cell and Gene Therapy Summit 2024 April 15th and 16th 2024,  Brussels Cell and gene therapies will reshape healthcare,

EAHAD Gene Therapy Webinar: Global distribution of gene therapy

EAHAD Gene Therapy Webinar: Global distribution of gene therapy Join us for an exploration of the global landscape of

microscope research grants

2024 EAHAD Research Grants cycle now open

2024 EAHAD Research Grants cycle now open We are very happy to announce that the 2024 EAHAD Research Grants

EAHAD 2024 Press Release

EAHAD 2024 Press Release Brussels, Belgium, 22 February 2024 – The European Association for Haemophilia and Allied Disorders (EAHAD)

Join us for the second E-Learning Live Discussion on EAHAD Academy on 26 October

Join us for the second E-Learning Live Discussion on the EAHAD Academy on 26 October 2023! Luciano Baronciani, Omid